ZNF302 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.970400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.495200E-01
Normal-vs-Stage2
4.422500E-03
Normal-vs-Stage3
3.803900E-02
Normal-vs-Stage4
1.821420E-01
Stage1-vs-Stage2
1.868220E-01
Stage1-vs-Stage3
7.049500E-02
Stage1-vs-Stage4
5.068000E-01
Stage2-vs-Stage3
1.459390E-01
Stage2-vs-Stage4
9.487600E-01
Stage3-vs-Stage4
3.031200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.401700E-02
Normal-vs-AfricanAmerican
4.771700E-02
Normal-vs-Asian
4.903800E-02
Caucasian-vs-AfricanAmerican
5.503400E-01
Caucasian-vs-Asian
5.261200E-01
AfricanAmerican-vs-Asian
8.995400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.595100E-03
Normal-vs-Female
1.611560E-01
Male-vs-Female
1.261220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.936400E-01
Normal-vs-Age(41-60Yrs)
6.222300E-02
Normal-vs-Age(61-80Yrs)
6.474000E-02
Normal-vs-Age(81-100Yrs)
1.655840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.837800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.772800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.754000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.311600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.456900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.688000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.480900E-03
Normal-vs-Daily Drinker
3.190200E-02
Normal-vs-Weekly Drinker
7.698800E-03
Normal-vs-Occasional Drinker
6.080400E-01
Normal-vs-Social Drinker
1.718360E-01
Non Drinker-vs-Daily Drinker
2.029800E-01
Non Drinker-vs-Weekly Drinker
5.624200E-01
Non Drinker-vs-Occasional Drinker
1.500560E-01
Non Drinker-vs-Social Drinker
2.256400E-02
Daily Drinker-vs-Weekly Drinker
5.591800E-01
Daily Drinker-vs-Occasional Drinker
3.480000E-01
Daily Drinker-vs-Social Drinker
2.815400E-01
Weekly Drinker-vs-Occasional Drinker
2.271600E-01
Weekly Drinker-vs-Social Drinker
1.228600E-01
Occasional Drinker-vs-Social Drinker
7.244200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.556400E-01
Normal-vs-Grade 2
2.202800E-01
Normal-vs-Grade 3
2.138600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.194200E-01
Grade 1-vs-Grade 3
2.682600E-01
Grade 1-vs-Grade 4
4.556400E-01
Grade 2-vs-Grade 3
7.606600E-01
Grade 2-vs-Grade 4
2.202800E-01
Grade 3-vs-Grade 4
2.138600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.688370E-01
Normal-vs-NonDiabetic
1.091230E-01
Diabetic-vs-NonDiabetic
1.091930E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.521700E-02
Normal-vs-NoPancreatitis
6.199600E-02
Pancreatitis-vs-NoPancreatitis
7.922200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.583400E-01
Normal-vs-N1
3.822200E-03
N0-vs-N1
3.650600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.235200E-01
Normal-vs-TP53-NonMutant
3.758800E-01
TP53-Mutant-vs-TP53-NonMutant
4.517200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
